Fresenius | FRE - Себестоимость





Себестоимость Изменить Дата
Akzo Nobel EUR 1.41B 28M 2026-03
Alcon AG USD 1.18B 26M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
BASF EUR 11.87B 941M 2026-03
Bayer EUR 5.23B 731M 2026-03
Beiersdorf EUR 2.06B 50M 2025-12
DaVita Healthcare Partners USD 2.52B 76.13M 2026-03
Demant DKK 2.89B 188M 2025-12
E.ON EUR 16.41B 114M 2026-03
Essilor EUR 6.06B 741M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Getinge SEK 6.02B 1.7B 2024-12
Givaudan CHF 2.07B 105M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GN Store Nord DKK 1.16B 1.08B 2026-03
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.46B 83M 2026-03
Philips EUR 2.14B 669M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
RWE EUR 3.21B 397M 2026-03
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12